Skip to main content
SpringerLink
Log in

Unterschätzter Faktor in der Hypertoniediagnostik?

Schlechte Adhärenz als Ursache einer pseudotherapieresistenten Hypertonie

  • Fortbildung
  • Schwerpunkt Hypertonie
  • Published:
CardioVasc Aims and scope

Die wichtigste Ursache der pseudotherapieresistenten arteriellen Hypertonie ist in bis zu 80% der Fälle eine unzureichende medikamentöse Adhärenz der Patienten. Durch z.B. die Bestimmung der Plasma- oder Urinkonzentrationen eingesetzter Antihypertensiva können die Adhärenz bestimmt und so Kosten durch Prävention von Folgeerkrankungen eingespart werden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Ettehad D, Emdin CA, Kiran A et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–67

    Article  Google Scholar 

  2. Kearney PM, Whelton M, Reynolds K et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23

    Article  Google Scholar 

  3. Chow CK, Teo KK, Rangarajan S et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–68

    Article  CAS  Google Scholar 

  4. Kotseva K, Wood D, De Bacquer D et al. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23(6):636–48

    Article  Google Scholar 

  5. Robert Koch-Institut, Epidemiologie und Gesundheitsberichterstattung, 2015

  6. Falaschetti E, Mindell J, Knott C, Poulter N. Hypertension management in England: a serial cross-sectional study from 1994 to 2011. Lancet. 2014;383(9932):1912–9

    Article  Google Scholar 

  7. Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104

    Article  Google Scholar 

  8. Noubiap JJ, Nansseu JR, Nyaga UF et al. Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients. Heart. 2018 Aug 7; https://doi.org/10.1136/heartjnl-2018-313599

    Article  Google Scholar 

  9. Abegaz TM, Shehab A, Gebreyohannes EA et al. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine (Baltimore). 2017;96(4):e5641

    Article  Google Scholar 

  10. Pladevall M, Brotons C, Gabriel R et al. Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study). Circulation. 2010;122(12):1183–91

    Article  Google Scholar 

  11. Gupta P, Patel P, Štrauch B et al. Risk Factors for Nonadherence to Antihypertensive Treatment. Hypertension. 2017;69(6):1113–20

    Article  CAS  Google Scholar 

  12. Gupta P, Patel P, Štrauch B et al. Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence. Hypertension. 2017;70(5):1042–8

    Article  CAS  Google Scholar 

  13. Koçkaya G, Wertheimer A. Can we reduce the cost of illness with more compliant patients? An estimation of the effect of 100% compliance with hypertension treatment. J Pharm Pract. 2011;24(3):345–50

    Article  Google Scholar 

  14. van Schoonhoven AV, van Asselt ADI, Tomaszewski M et al. Cost-Utility of an Objective Biochemical Measure to Improve Adherence to Antihypertensive Treatment. Hypertension. 2018;72(5):1117–24

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Charité — Universitätsmedizin Berlin, Campus Benjamin Franklin Med. Klinik mit SP Nephrologie, Hindenburgdamm 30, 12203, Berlin, Deutschland

    Markus Tölle

Authors
  1. Markus Tölle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Markus Tölle.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tölle, M. Schlechte Adhärenz als Ursache einer pseudotherapieresistenten Hypertonie. CV 19, 44–47 (2019). https://doi.org/10.1007/s15027-019-1514-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15027-019-1514-4

Search

Navigation